Asia Pacific Healthcare Market

Asia Pacific Healthcare Market Outlook [By Health Indicators (Life Expectancy, Mortality), Disease Burden (Epidemiology, Average Cost Of Therapy), Health System (Infrastructure, Expenditure), Regulatory Landscape] - Analysis & Forecast To 2020

Report Code: UC 1562 Jun, 2024, by

The APAC region showcases diverse healthcare challenges across various countries. These range from improving healthcare access in developing countries of Vietnam to tackling rising diabetes, cancer, and cardiovascular diseases in well developed nations of Japan and Pacific countries. In addition, regions of China and India that lie in between developing and well developed countries are facing increase in diseases burden, problems of poverty, limited access to high quality treatment, and slow increase in disposable income. The APAC Healthcare Market Outlook examines the health indicators and healthcare system across India, China, Japan, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Australia, and New Zealand.

The APAC Healthcare Market Outlook is segmented into five broad categories: health status, healthcare system assessment, healthcare regulatory landscape, medical devices infrastructure assessment, hospital chain assessment in top 10 hospitals.

The health status covers health indicators (life expectancy, mortality, and aging population assessment) and disease burden assessment (top 10 diseases and government initiative to address the disease burden).

The healthcare system assessment comprises infrastructure assessment (number of public and private hospitals by bed strength, number of public and private medical colleges, and number of health community centers), healthcare expenditure (healthcare spending per capita, public expenditure on health as a percentage of GDP, total expenditure on health as a percentage of GDP, and per capita government expenditure on health at average exchange rate in USD), and insurance landscape (extent of public, private, and out-of-pocket insurance coverage, number of public and private insurance companies, and government sponsored health insurance schemes).

The healthcare regulatory landscape covers assessment of healthcare regulatory bodies (healthcare providers, healthcare payers, and medical devices) and medical device registration process (procedure, documents/dossier required, timeline, and fees), and regulatory reforms.

The medical device infrastructure assessment is segmented into installed base of medical devices (MRI, CT Scans, Ultrasound, and X-rays) and medical devices infrastructure improvement initiatives undertaken by government and medical device manufacturers. The hospital chain assessment in top 10 hospitals in each country assesses the overview, services offered, financial performance, key growth strategies, and recent developments for each hospitals.

Table Of Contents

1  Health Status
     1.1 Health Indicators
            1.1.1 Life Expectancy
            1.1.2 Mortality Rate
             Overall Mortality Rate
             Under-Five Mortality Rate
             Infant Mortality Rate
             Neo-Natal Mortality Rate
            1.1.3 Aging Population Assessment
                         Current (2014)
                         Projected (2020)
                         Current (2014)
                         Projected (2020)
     1.2 Disease Burden Assessment
            1.2.1 Top 10 Diseases
             Diagnostic Rate
             Treatment Rate
             Treament Options
             Average Cost Of Therapy
            1.2.2 Government Initatives (To Address Disease Burden)

2 Healthcare System Assessment
     2.1 Infrastructure Assessment
            2.1.1 Hospitals
             Number Of Public Hospitals, by Bed Strength
                         Below 100
                         100 To 300
                         300 and Above
             Number Of Private Hospitals, by Bed Strength
                         Below 100
                         100 To 300
                         300 and Above
            2.1.2 Number Of Diagnostic Centers/Clinics
            2.1.3 Number Of Medical Colleges
            2.1.4 Number Of Health Community Centers
             Cardiovascular Centers
             Orthopedic Centers
             Maternity Centers
             Dental Centers
     2.2 Healthcare Expenditure
            2.2.1 Healthcare Spending/Capita
            2.2.2 Public Expenditure On Health As A Percentage Of GDP
            2.2.3 Total Expenditure On Health As A Percentage Of GDP
            2.2.4 Per Capita Government Expenditure On Health At Average Exchange Rate (USD)
     2.3 Insurance Landscape
            2.3.1 Extent Of Insurance Coverage
            2.3.2 Number Of Insurance Companies
            2.3.3 Government Sponsored Health Insurance Schemes

3 Healthcare Regulatory Landscape
     3.1 Healthcare Regulatory Bodies
            3.1.1 Healthcare Providers
            3.1.2 Healthcare Payers
            3.1.3 Medical Devices
     3.2 Medical Device Registration Process
            3.2.1 Procedure
            3.2.2 Documents/Dossiers Required
            3.2.3 Timeline
            3.2.4 Fees
     3.3 Regulatory Reforms (If Applicable)

4 Medical Devices Infrastructure Assessment
     4.1 Installed Base (2014)
            4.1.1 Mri
            4.1.2 Ct Scans
            4.1.3 Ultrasound
            4.1.4 X-Rays
     4.2 Medical Devices Infrastructure Improvement Initiatives
            4.2.1 Government
            4.2.2 Medical Device Manufacturers

5 Hospital Chain Assessment In Top 10 Hospitals
     5.1 Hospital 1
            5.1.1 Overview
            5.1.2 Service Offerings
            5.1.3 Financial Performance
            5.1.4 Key Growth Strategy
            5.1.5 Developments
     5.2 Hospital 2
     5.3 Hospital 3
     5.4 Hospital 4
     5.5 Hospital 5
     5.6 Hospital 6
     5.7 Hospital 7
     5.8 Hospital 8
     5.9 Hospital 9
     5.10 Hospital 10

6 Geographic Scope:
     6.1. India
     6.2. China
     6.3. Japan
     6.4. Singapore
     6.5. Indonesia
     6.6. Thailand
     6.7. Malaysia
     6.8. Vietnam
     6.9. Australia
     6.10. New Zealand 

*Top 10 companies in the market will be covered
#Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
6 0 7 9 5  
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
UC 1562
Available for Pre-Book
Choose License Type
Prebook Now
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Asia Pacific Healthcare Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status Website Feedback